Efficacy test of Trichoben vaccine administered to calves at different intervals between vaccination and re-vaccination

被引:2
|
作者
Rybnikar, A. [1 ]
Oborilova, E. [1 ]
Hedbavny, R. [1 ]
机构
[1] Bioveta AS, Ivanovice Na Hane 68323, Czech Republic
关键词
cattle; post-vaccination immunity; challenge; Trichophyton verrucosum;
D O I
10.2754/avb200877020239
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to test a possible extension of the period between vaccination and re-vaccination with the live Trichoben vaccine (Bioveta, a.s., Czech Republic). The calves (n = 61) were vaccinated intramuscularly. The intervals between vaccination and re-vaccination were 3, 5, 7, 10, 14 or 28 days. Another group of calves (n = 16) was vaccinated once with a double dose of the vaccine. The protective immunity against experimental infection with a virulent Trichophyton verrucosum CCM F-650 strain was investigated in animals one month after the last vaccination and compared with a group of non-vaccinated controls (n = 16). Clinical results were evaluated and compared using balanced two-way-ANOVA. The level of post-vaccination immunity in cattle after re-vaccination was sufficient when the intervals were 5, 7, 10, 14 and 28 days. One-time injection of a double prophylactic dose of the vaccine and a 3-day interval between vaccinations reduced the immunity and vaccine efficacy to an unsatisfactory degree. There were significant differences between the groups of calves vaccinated using an interval longer than 5 days, and the group vaccinated once with a double dose, and the group with a 3-day interval between vaccinations. The level of post-vaccination immunity in cattle after re-vaccination at the commonly used interval of 10 - 14 days was identical with the immunity achieved when the interval was reduced to 5 or 7 days or extended up to 28 days. The extension of the interval between vaccinations to 5 - 28 days is recommended for using the Trichoben vaccine in veterinary practice.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 50 条
  • [31] An investigation of the efficacy of a polyvalent mastitis vaccine using different vaccination regimens under field conditions in the United King dom
    Bradley, A. J.
    Breen, J. E.
    Payne, B.
    White, V.
    Green, M. J.
    [J]. JOURNAL OF DAIRY SCIENCE, 2015, 98 (03) : 1706 - 1720
  • [32] Immunogenicity and Persistence of a Prime-Boost Re-Vaccination Strategy for Pneumococcal Vaccines (13-Valent Pneumococcal Conjugate Vaccine+23-Valent Pneumococcal Polysaccharide Vaccine) in Patients with Rheumatoid Arthritis: A Pilot Study
    Bahuaud, Mathilde
    Beaudouin, Constance
    Molto, Anna
    Launay, Odile
    Batteux, Frederic
    Dougados, Maxime
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [33] Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration
    Hodgson, JC
    Finucane, A
    Dagleish, MP
    Ataei, S
    Parton, R
    Coote, JG
    [J]. INFECTION AND IMMUNITY, 2005, 73 (03) : 1475 - 1481
  • [34] Protection Efficacy of the Infectious Laryngotracheitis (ILT) Serva CEO Vaccine Strain in Broiler Chickens Under Different Vaccination Coverage Conditions
    Assen, Awol M.
    Gerber, Priscilla F.
    Walkden-Brown, Stephen W.
    [J]. AVIAN DISEASES, 2023, 67 (02) : 160 - 169
  • [35] Comparative Efficacy of an Intensified Re-Vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected with HIV (CORE-HIV): A Randomized Controlled Trial. Interim Analysis
    Vargas, Jose Ignacio
    Jensen, Daniela
    Martinez, Felipe
    Sarmiento, Valeska
    Acuna, Pedro
    Peirano, Felipe
    Fuster, Francisco
    [J]. HEPATOLOGY, 2016, 64 : 876A - 877A
  • [36] Efficacy of different vaccination programs of recombinant HVT-NDV vaccine against genotype VII NDV Challenge in broiler chickens
    Charoenvisal, Nataya
    Supannamoke, Bubpa
    Koopman, Rik
    Sasipreeyajan, Jiroj
    [J]. THAI JOURNAL OF VETERINARY MEDICINE, 2018, 48 (04): : 603 - 611
  • [37] Rituximab-treated Rheumatic Patients: B-cell Levels Predict Sero-conversion After COVID-19 Boost or Re-vaccination in Initial Vaccine Non-responders
    Ammitzboell, Christian
    Thomsen, Marianne Kragh
    Andersen, Jakob Bogn
    Jensen, Jens Magnus Berth
    Hermansen, Marie-Louise From
    Johannsen, Anders Dahl
    Larsen, Mads Lamm
    Mistegaard, Clara Elbael
    Mikkelsen, Susan
    Szabados, Fruzsina
    Vils, Signe Risbol
    Erikstrup, Christian
    Hauge, Ellen-Margrethe
    Troldborg, Anne
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1517 - 1520
  • [38] Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules
    Giammanco, G
    Moiraghi, A
    Zotti, C
    Pignato, S
    Li Volti, S
    Giammanco, A
    Soncini, R
    [J]. VACCINE, 1998, 16 (07) : 722 - 726
  • [39] Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees
    Garner-Spitzer, Erika
    Kundi, Michael
    Rendi-Wagner, Pamela
    Winkler, Birgit
    Wiedermann, Gerhard
    Holzmann, Heidemarie
    Herzog, Christian
    Kollaritsch, Herwig
    Wiedermann, Ursula
    [J]. VACCINE, 2009, 27 (02) : 197 - 204
  • [40] Associations between risk-perception, self-efficacy and vaccine response-efficacy and parent/guardian decision-making regarding adolescent HPV vaccination
    Myhre, Alicia
    Xiong, Tiaj
    Vogel, Rachel, I
    Teoh, Deanna
    [J]. PAPILLOMAVIRUS RESEARCH, 2020, 10